Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Free Cash Flow: 2011-2024

Historic Free Cash Flow for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $11.9 million.

  • Niagen Bioscience's Free Cash Flow rose 6.20% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year increase of 420.89%. This contributed to the annual value of $11.9 million for FY2024, which is 71.42% up from last year.
  • Latest data reveals that Niagen Bioscience reported Free Cash Flow of $11.9 million as of FY2024, which was up 71.42% from $7.0 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Free Cash Flow ranged from a high of $11.9 million in FY2024 and a low of -$24.6 million during FY2021.
  • Moreover, its 3-year median value for Free Cash Flow was $7.0 million (2023), whereas its average is $1.2 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 129.13% in 2021, then skyrocketed by 145.16% in 2023.
  • Niagen Bioscience's Free Cash Flow (Yearly) stood at -$10.7 million in 2020, then slumped by 129.13% to -$24.6 million in 2021, then skyrocketed by 37.20% to -$15.4 million in 2022, then spiked by 145.16% to $7.0 million in 2023, then soared by 71.42% to $11.9 million in 2024.